Quantum computing has long been described as a technology perpetually a decade away from practical relevance. However, recent advancements in the technology may bring quantum computing to bear sooner than projected. Three areas of recent progress tell that story: hardware stability, real-world problem-solving, and the resource requirements for error correction. In each, results have arrived sooner than most of the research community predicted.
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavequantum.com .
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavequantum.com .
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced that it will host its first-ever Investor Day, on June 1, 2026, at the New York Stock Exchange (the “NYSE”) and online.
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced that management will be participating in the following investor conferences:
Just a few years ago, San Francisco was widely portrayed as a city in decline. Attention in the American tech scene appeared to be shifting toward Austin, New York, and Miami. That perception has changed sharply with the rise of artificial intelligence, which has pulled the city back into the center of global innovation.
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavequantum.com .
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: ir.dwavequantum.com.
The United Nations World Food Program (WFP) has introduced a new artificial intelligence program designed to track and monitor hunger risks across the world. The platform, known as HungerMap Live, is expected to change how governments and humanitarian organizations respond to food crises by offering early warnings and real-time data.
Most digital communications are secured by encryption built on mathematical problems so hard that conventional computers cannot realistically solve them. That assumption could soon be broken by quantum computers that exploit properties of matter at subatomic scales to perform certain calculations far more efficiently than conventional machines ever could.
A new study suggests that generative AI has yet to develop the level of reasoning required for safe use in clinical settings. While recent systems show stronger performance when given detailed patient information, researchers found they still struggle with one of the most critical aspects of medical decision-making.
